Correlation Between Cardano and Excelsior Biopharma

Can any of the company-specific risk be diversified away by investing in both Cardano and Excelsior Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardano and Excelsior Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardano and Excelsior Biopharma, you can compare the effects of market volatilities on Cardano and Excelsior Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardano with a short position of Excelsior Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardano and Excelsior Biopharma.

Diversification Opportunities for Cardano and Excelsior Biopharma

0.11

Correlation Coefficient

Cardano  Excelsior Biopharma

Average diversification

The 3 months correlation between Cardano and Excelsior is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Cardano and Excelsior Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Excelsior Biopharma and Cardano is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardano are associated (or correlated) with Excelsior Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Excelsior Biopharma has no effect on the direction of Cardano i.e., Cardano and Excelsior Biopharma go up and down completely randomly.

Pair Corralation between Cardano and Excelsior Biopharma

Assuming the 90 days trading horizon Cardano is expected to under-perform the Excelsior Biopharma. In addition to that, Cardano is 3.3 times more volatile than Excelsior Biopharma. It trades about -0.09 of its total potential returns per unit of risk. Excelsior Biopharma is currently generating about 0.29 per unit of volatility. If you would invest  2,995  in Excelsior Biopharma on October 11, 2024 and sell it today you would earn a total of  390.00  from holding Excelsior Biopharma or generate 13.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cardano  vs.  Excelsior Biopharma

Cardano

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cardano are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Cardano exhibited solid returns over the last few months and may actually be approaching a breakup point.

Excelsior Biopharma

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Excelsior Biopharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Excelsior Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardano and Excelsior Biopharma

The main advantage of trading using opposite Cardano and Excelsior Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardano position performs unexpectedly, Excelsior Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Excelsior Biopharma will offset losses from the drop in Excelsior Biopharma's long position.

The idea behind Cardano and Excelsior Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.